Cameron Durrant's Net Worth

$1.5 Million

Estimate Recalculated Jun 17, 2024 06:32AM EST

Who is Cameron Durrant?

Cameron Durrant has an estimated net worth of $1.5 Million. This is based on reported shares across multiple companies, which include PediatRx Inc., ANAVEX LIFE SCIENCES CORP., HUMANIGEN, INC, HI TECH PHARMACAL CO INC, and IMMUNE PHARMACEUTICALS INC.

SEC CIK

Cameron Durrant's CIK is 0001421882

Past Insider Trading and Trends

2018 was Cameron Durrant's most active year for acquiring shares with 7 total transactions. Cameron Durrant's most active month to acquire stocks was the month of November. 2021 was Cameron Durrant's most active year for disposing of shares, totalling 5 transactions. Cameron Durrant's most active month to dispose stocks was the month of May. 2020 saw Cameron Durrant paying a total of $342,241.20 for 650,725 shares, this is the most they've acquired in one year. In 2021 Cameron Durrant cashed out on 210,542 shares for a total of $1,760,934.22, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

PediatRx Inc. (THER) Snapshot price: $0.001

President, CEO, CFO, Treasurer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-4.25M
$0.01
-$51,000.00
0
Apr 5
Form 4
—
0
—
—
0
Form 3
—
0
—
—
0
No matching records found

ANAVEX LIFE SCIENCES CORP. (AVXL) Snapshot price: $5.94

Executive Chairman

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Form 4
—
0
—
—
0
Jun 29
Form 4
—
0
—
—
0
Form 4
-100.00%
-75.00K
—
—
0
May 20 - Jun 18
Form 3
—
0
—
—
0
No matching records found

HUMANIGEN, INC (HGEN) Snapshot price: $0.0002

Chief Executive Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jul 27
Form 4
+133.33%
40K
$2.34
$93,600.00
70K
Mar 2
Form 4
—
0
—
—
0
Jan 12
Form 4
—
0
—
—
0
Dec 31
Form 4
—
0
—
—
0
Nov 23
Form 4
—
0
—
—
0
Sep 30
Form 4
-73.08%
-81.44K
$20.64
-$1,680,934.42
30K
Mar 1 - Jun 14
Form 4
—
0
—
—
0
Mar 12
Form 4
—
0
—
—
0
Oct 5
Form 4
—
0
—
—
0
May 20
Form 4
—
0
—
—
0
Jan 28
Form 4
+1.46%
8K
$1.25
$10,000.00
557.21K
Jun 4
Form 4
+75.14%
235.62K
—
—
549.21K
May 31
Form 4
+31.44%
75K
$0.67
$49,875.00
313.58K
Apr 23
Form 4
+45.85%
75K
$0.67
$49,875.00
238.58K
Mar 8
Form 4
—
0
—
—
0
Jan 25
Form 4
+3.81%
6K
$0.82
$4,907.80
163.58K
Dec 12 - Dec 14
Form 4
+3.28%
5K
$0.75
$3,767.50
157.58K
Dec 10 - Dec 11
Form 4
+12.54%
17K
$0.73
$12,493.00
152.58K
Dec 6 - Dec 7
Form 4
—
0
—
—
0
Mar 9
Form 4
—
0
—
—
0
Sep 13
Form 4
∞
135.58K
—
—
135.58K
Jun 30
Form 3
—
0
—
—
0
No matching records found

HI TECH PHARMACAL CO INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Mar 11
Form 3
—
0
—
—
0
No matching records found

IMMUNE PHARMACEUTICALS INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jan 25
Form 4
—
0
—
—
0
Jun 1
Form 4
—
0
—
—
0
Jan 29
Form 4
—
0
—
—
0
Jan 8
Form 4
∞
4K
$2.50
$10,000.00
4K
Nov 26
Form 4
—
0
—
—
0
Jul 10
Form 3
—
0
—
—
0
No matching records found